Abstract:
Amphiphilic polyamide compounds and derivatives thereof having the property of promoting transfection of polynucleotides and polypeptides into cells, and formulations comprising said compounds.
Abstract:
Lung cancer is one of the most commonly diagnosed cancers in the world. While numerous predictive genetic models of non-small cell lung cancer (NSCLC) have been proposed, but many current models fail to accurately predict patient survival when verified by other multiple datasets. Here, we successfully eliminated institutional variations and merged twelve datasets from different institutions to generate a training cohort of 1073 and a testing cohort of 659. From the training cohort, we identified 129 deferentially expressed probes or 95 genes (Table1-2) associated with Lung Cancer.Here we showed that using seven genes from Table1-2 and combined these genes values with the clinical parameters of age and cancer stage to design the Lung Cancer Prognostic Index (LCPI). Using the LCPI, we were able to differentiate patient populations into low, intermediate, and high risk groups and predict patient survival probabilities for all stages and all cell types of NSCLC at 10 and 15 years. The overall survival probability of low risk group defined by LCPI at 15 years was 65%-100%. Those lung cancer patients were surgical curable. Any post-surgery treatment like ACT (adjuvant chemotherapy) might actually decrease survival probabilities or shorten the life of those patients.We extensively verified the predictive ability of the LCPI model for overall survival and recurrence free survival using six datasets (n=1665) from five different countries, which included samples of multiple cancer stages and all cell types. Using this model, clinicians would be able to prevent thousands of NSCLC patients from receiving excessive and unnecessary treatments and ultimately prolong their lives.This research has been published in the first issue of “EbioMedicine” (http://www.ebiomedicine.com/article/S2352-3964%2814%2900014-0/fulltext) which is a high quality peer review journal under editorial leadership of “Cell Press” and “The Lancet”.
Abstract:
The present invention relates to a method of fabricating a through silicon via (TSV) structure, in which, a dielectric layer is disposed to cover surface of each of a device region of a substrate and a sidewall and a bottom of a via hole in a TSV region of the substrate, and the via hole having the dielectric layer covering the sidewall and the bottom is filled with a conductive material. The present invention also relates to a TSV structure, in which, a dielectric layer disposed in the device region of a substrate extends to the via hole in a TSV region of the substrate to cover surface of the sidewall of the via hole to serve as a dielectric liner, and a conductive material is filled into the via hole having the dielectric layer covering the sidewall.
Abstract:
The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter compounds present in, e.g., coffee. Also, the invention relates to the discovery of specific compounds and compositions containing that function as bitter taste blockers and the use thereof as bitter taste blockers or flavor modulators in, e.g., coffee and coffee flavored foods, beverages and medicaments. Also, the present invention relates to the discovery of a compound that antagonizes numerous different human T2Rs and the use thereof in assays and as a bitter taste blocker in compositions for ingestion by humans and animals.
Abstract:
In one embodiment, a method comprises receiving a plurality of data frames representing at least one virtually concatenated data stream, storing the plurality of data frames in a memory; and recording, for each of a plurality of data frames, a physical write address that indicates a position in the memory and a virtual write address that includes a multiframe indicator and a byte number indicator.
Abstract:
A device for mapping and demapping cells in an orderly manner is provided. The device employs a channel identifier and in certain configurations a buffer and series of stages to provide for relatively ordered, predictable mapping and demapping of data, such as virtual concatenation data.
Abstract:
In a communication system that uses virtually concatenated payloads, techniques to determine when to declare and when to clear alarm indication signal (AIS) for a group. The declaration of AIS for a group may occur based on when declaration of AIS for a member of a group occurs. The clearing of group AIS may occur based on when clearing of AIS by a last member of a group to clear AIS occurs.
Abstract:
A method for showing a component on a user interface is disclosed. A style maker provides some style options, each style option including associated configurations. When constructing the component on the user interface, one of the style options is selected for showing the component. In this manner, the constructed component is distinctly displayed on the user interface responding to the respective event.
Abstract:
A memory is divided into a number of partitions. The partitions are grouped into a first group of partitions and a second group of partitions. When required by a port, a partition is assigned to the port from a pool of un-assigned partitions. The pool of un-assigned partitions comprises of un-assigned partitions from the first group of partitions and un-assigned partitions from the second group of partitions. The un-assigned partitions from the first group of partitions are assigned to the port until a first threshold is reached. The un-assigned partitions from the second group of partitions are assigned to the port after the first threshold is reached. A second threshold is used to limit a total number of partitions assigned to the port.
Abstract:
The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter compounds present in, e.g., coffee. Also, the invention relates to the discovery of specific compounds and compositions containing that function as bitter taste blockers and the use thereof as bitter taste blockers or flavor modulators in, e.g., coffee and coffee flavored foods, beverages and medicaments. Also, the present invention relates to the discovery of a compound that antagonizes numerous different human T2Rs and the use thereof in assays and as a bitter taste blocker in compositions for ingestion by humans and animals.